FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Congress Unveils FDA User Fee Reauthorization Package April 14, 2017 Drug Recalls Were Down in 2021 But Appear Back on the Rise as Pandemic Slows, Says Report March 6, 2022 J&J, Janssen Biotech Enter $25M Settlement Over Alleged Remicade Antitrust Scheme March 19, 2023
Drug Recalls Were Down in 2021 But Appear Back on the Rise as Pandemic Slows, Says Report March 6, 2022
